News

Pharmabiz3m
AI & biosensing technologies shaping health-tech start-ups to drive innovation in chronic disease prediction
AI & biosensing technologies shaping health-tech start-ups to drive innovation in chronic disease prediction: Nandita Vijayasimha, Bengaluru Saturday, August 2, 2025, 08:00 Hrs [I ...
Pharmabiz3m
Karnataka strengthens cleft lip & cleft palate care by training maxillofacial surgeons
Karnataka strengthens cleft lip & cleft palate care by training maxillofacial surgeons: Nandita Vijayasimha, Bengaluru Saturday, August 2, 2025, 08:00 Hrs [IST] Karnataka governme ...
Pharmabiz5m
Health ministry amends Cosmetics Rules, 2020 to add specifics for cancellation & suspension of licence
The Union health ministry has notified amendments to the Cosmetics Rules, 2020 adding provisions for cancellation and suspension of licenses and clarifying the definition of ‘use before’ and ‘date of ...
Pharmabiz14h
Harbour BioMed to present phase II data of HBM4003 & tislelizumab combination in MSS metastatic colorectal cancer at ESMO 2025
Harbour BioMed to present phase II data of HBM4003 & tislelizumab combination in MSS metastatic colorectal cancer at ESMO 2025: Cambridge, Massachusetts Friday, August 1, 2025, 18 ...
Pharmabiz14h
Maxivision Super Speciality Eye Hospital launches 10 super speciality eye hospitals across Chennai
Maxivision Super Speciality Eye Hospital launches 10 super speciality eye hospitals across Chennai: Our Bureau, Mumbai Friday, August 1, 2025, 17:40 Hrs [IST] Maxivision Super Spe ...
Pharmabiz15h
Cardiosense receives US FDA 510(k) clearance for its CardioTag device
Cardiosense receives US FDA 510(k) clearance for its CardioTag device: Chicago Friday, August 1, 2025, 17:00 Hrs [IST] Cardiosense, a medical AI company transforming cardiovascula ...
Pharmabiz16h
Novo Nordisk appoints Mike Doustdar as new president and CEO
Novo Nordisk, a Danish multinational pharmaceutical company headquartered in Bagsværd with production facilities in nine ...
Pharmabiz17h
Madrigal Pharma inks exclusive global license agreement with CSPC Pharma for SYH2086, a preclinical oral small molecule GLP-1 receptor agonist
Conshohocken, Pa. Friday, August 1, 2025, 15:00 Hrs [IST] ...
Pharmabiz18h
Aclaris Therapeutics announces positive top-line results from phase 2a clinical trial of ATI-2138
Aclaris Therapeutics announces positive top-line results from phase 2a clinical trial of ATI-2138: Wayne, Pennsylvania Friday, August 1, 2025, 14:00 Hrs [IST] Aclaris Therapeutics ...
Pharmabiz19h
Egg Medical announces USPTO issues final rejection of all claims in Rampart IC's radiation shield patent following a reexamination challenge
Egg Medical announces USPTO issues final rejection of all claims in Rampart IC's radiation shield patent following a reexamination challenge: St. Paul, Minn. Friday, August 1, 202 ...
Pharmabiz19h
Sun Pharma net profit declines 20 per cent in Q1FY26
Sun Pharmaceutical Industries reported a decline of 20 per cent in net profit at Rs. 2,278.63 crore during the first quarter of the current fiscal year, as compared to Rs. 2,835.62 crore during the ...
Pharmabiz20h
Illumina introduces next generation cancer research assay, TruSight Oncology 500
Illumina introduces next generation cancer research assay, TruSight Oncology 500: San Diego Friday, August 1, 2025, 12:00 Hrs [IST] Illumina Inc., a biotechnology company develops ...